-
1
-
-
34848837386
-
Taking dendritic cells into medicine
-
Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419-426.
-
(2007)
Nature
, vol.449
, pp. 419-426
-
-
Steinman, R.M.1
Banchereau, J.2
-
2
-
-
58649089564
-
Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines
-
Dohnal AM, Graffi S, Witt V, et al. Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines. J Cell Mol Med. 2009;13:125-135.
-
(2009)
J Cell Mol Med
, vol.13
, pp. 125-135
-
-
Dohnal, A.M.1
Graffi, S.2
Witt, V.3
-
3
-
-
36849005123
-
Phase i study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer
-
Dohnal AM, Witt V, Hugel H, et al. Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer. Cytotherapy. 2007;9:755-770.
-
(2007)
Cytotherapy
, vol.9
, pp. 755-770
-
-
Dohnal, A.M.1
Witt, V.2
Hugel, H.3
-
4
-
-
22044441249
-
Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses
-
Felzmann T, Huttner KG, Breuer SK, et al. Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses. Cancer Immunol Immunother. 2005;54:769-780.
-
(2005)
Cancer Immunol Immunother
, vol.54
, pp. 769-780
-
-
Felzmann, T.1
Huttner, K.G.2
Breuer, S.K.3
-
5
-
-
11244352173
-
Generation of potent anti-tumor immunity in mice by interleukin-12- secreting dendritic cells
-
Huttner KG, Breuer SK, Paul P, et al. Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells. Cancer Immunol Immunother. 2005;54:67-77.
-
(2005)
Cancer Immunol Immunother
, vol.54
, pp. 67-77
-
-
Huttner, K.G.1
Breuer, S.K.2
Paul, P.3
-
6
-
-
33846454363
-
Perspectives of gammadelta T cells in tumor immunology
-
Kabelitz D, Wesch D, He W. Perspectives of gammadelta T cells in tumor immunology. Cancer Res. 2007;67:5-8.
-
(2007)
Cancer Res
, vol.67
, pp. 5-8
-
-
Kabelitz, D.1
Wesch, D.2
He, W.3
-
7
-
-
34548307280
-
Human gamma delta T cells: Candidates for the development of immunotherapeutic strategies
-
Beetz S, Marischen L, Kabelitz D, et al. Human gamma delta T cells: candidates for the development of immunotherapeutic strategies. Immunol Res. 2007;37:97-111.
-
(2007)
Immunol Res
, vol.37
, pp. 97-111
-
-
Beetz, S.1
Marischen, L.2
Kabelitz, D.3
-
8
-
-
0033015423
-
Gamma delta T cells, their T cell receptor usage and role in human diseases
-
Kabelitz D, Wesch D, Hinz T. Gamma delta T cells, their T cell receptor usage and role in human diseases. Springer Semin Immunopathol. 1999;21:55-75.
-
(1999)
Springer Semin Immunopathol
, vol.21
, pp. 55-75
-
-
Kabelitz, D.1
Wesch, D.2
Hinz, T.3
-
9
-
-
33644779729
-
Immunosurveillance and immunoregulation by gammadelta T cells
-
Girardi M. Immunosurveillance and immunoregulation by gammadelta T cells. J Invest Dermatol. 2006;126:25-31.
-
(2006)
J Invest Dermatol
, vol.126
, pp. 25-31
-
-
Girardi, M.1
-
10
-
-
0037121943
-
CD1-mediated gamma/delta T cell maturation of dendritic cells
-
Leslie DS, Vincent MS, Spada FM, et al. CD1-mediated gamma/delta T cell maturation of dendritic cells. J Exp Med. 2002;196:1575-1584.
-
(2002)
J Exp Med
, vol.196
, pp. 1575-1584
-
-
Leslie, D.S.1
Vincent, M.S.2
Spada, F.M.3
-
11
-
-
33947269166
-
CD1-restricted recognition of exogenous and self-lipid antigens by duodenal gammadelta+ T lymphocytes
-
Russano AM, Bassotti G, Agea E, et al. CD1-restricted recognition of exogenous and self-lipid antigens by duodenal gammadelta+ T lymphocytes. J Immunol. 2007;178:3620-3626.
-
(2007)
J Immunol
, vol.178
, pp. 3620-3626
-
-
Russano, A.M.1
Bassotti, G.2
Agea, E.3
-
12
-
-
0034689029
-
Self-recognition of CD1 by gamma/delta T cells: Implications for innate immunity
-
Spada FM, Grant EP, Peters PJ, et al. Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med. 2000;191:937-948.
-
(2000)
J Exp Med
, vol.191
, pp. 937-948
-
-
Spada, F.M.1
Grant, E.P.2
Peters, P.J.3
-
13
-
-
10844263473
-
Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid
-
Poggi A, Venturino C, Catellani S, et al. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid. Cancer Res. 2004;64:9172-9179.
-
(2004)
Cancer Res
, vol.64
, pp. 9172-9179
-
-
Poggi, A.1
Venturino, C.2
Catellani, S.3
-
14
-
-
0033536068
-
Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB
-
Groh V, Rhinehart R, Secrist H, et al. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA. 1999; 96:6879-6884.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 6879-6884
-
-
Groh, V.1
Rhinehart, R.2
Secrist, H.3
-
15
-
-
45149144765
-
Subpopulations of human peripheral T gamma delta lymphocytes
-
Triebel F, Hercend T. Subpopulations of human peripheral T gamma delta lymphocytes. Immunol Today. 1989;10:186-188.
-
(1989)
Immunol Today
, vol.10
, pp. 186-188
-
-
Triebel, F.1
Hercend, T.2
-
16
-
-
18044394756
-
Sensing cell stress and transformation through Vgamma9Vdelta2 T cell-mediated recognition of the isoprenoid pathway metabolites
-
Bonneville M, Fournie JJ. Sensing cell stress and transformation through Vgamma9Vdelta2 T cell-mediated recognition of the isoprenoid pathway metabolites. Microbes Infect. 2005;7: 503-509.
-
(2005)
Microbes Infect
, vol.7
, pp. 503-509
-
-
Bonneville, M.1
Fournie, J.J.2
-
17
-
-
0037455013
-
Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells
-
Gober HJ, Kistowska M, Angman L, et al. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med. 2003;197:163-168.
-
(2003)
J Exp Med
, vol.197
, pp. 163-168
-
-
Gober, H.J.1
Kistowska, M.2
Angman, L.3
-
18
-
-
1642526540
-
Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro
-
Thompson K, Rogers MJ. Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro. J Bone Miner Res. 2004;19:278-288.
-
(2004)
J Bone Miner Res
, vol.19
, pp. 278-288
-
-
Thompson, K.1
Rogers, M.J.2
-
19
-
-
30444431620
-
Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway
-
Thompson K, Rojas-Navea J, Rogers MJ. Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood. 2006;107:651-654.
-
(2006)
Blood
, vol.107
, pp. 651-654
-
-
Thompson, K.1
Rojas-Navea, J.2
Rogers, M.J.3
-
20
-
-
26844476689
-
V gamma 9V delta 2 T cell response to colon carcinoma cells
-
Corvaisier M, Moreau-Aubry A, Diez E, et al. V gamma 9V delta 2 T cell response to colon carcinoma cells. J Immunol. 2005;175:5481-5488.
-
(2005)
J Immunol
, vol.175
, pp. 5481-5488
-
-
Corvaisier, M.1
Moreau-Aubry, A.2
Diez, E.3
-
21
-
-
0034897362
-
MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function
-
Das H, Groh V, Kuijl C, et al. MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity. 2001;15:83-93.
-
(2001)
Immunity
, vol.15
, pp. 83-93
-
-
Das, H.1
Groh, V.2
Kuijl, C.3
-
22
-
-
23444445748
-
Activation of v gamma 9V delta 2 T cells by NKG2D
-
Rincon-Orozco B, Kunzmann V, Wrobel P, et al. Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol. 2005; 175:2144-2151.
-
(2005)
J Immunol
, vol.175
, pp. 2144-2151
-
-
Rincon-Orozco, B.1
Kunzmann, V.2
Wrobel, P.3
-
23
-
-
19944432463
-
Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I
-
Scotet E, Martinez LO, Grant E, et al. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity. 2005;22:71-80.
-
(2005)
Immunity
, vol.22
, pp. 71-80
-
-
Scotet, E.1
Martinez, L.O.2
Grant, E.3
-
24
-
-
34548024379
-
Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway
-
Peng G, Wang HY, Peng W, et al. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity. 2007;27:334-348.
-
(2007)
Immunity
, vol.27
, pp. 334-348
-
-
Peng, G.1
Wang, H.Y.2
Peng, W.3
-
25
-
-
0028026050
-
Rapid quantification of lymphocyte subsets in heterogeneous cell populations by flow cytometry
-
Pechhold K, Pohl T, Kabelitz D. Rapid quantification of lymphocyte subsets in heterogeneous cell populations by flow cytometry. Cytometry. 1994;16:152-159.
-
(1994)
Cytometry
, vol.16
, pp. 152-159
-
-
Pechhold, K.1
Pohl, T.2
Kabelitz, D.3
-
26
-
-
0031569215
-
Activation of human gamma delta T cells by Mycobacterium tuberculosis and Daudi lymphoma cells: Differential regulatory effect of IL-10 and IL-12
-
Marx S, Wesch D, Kabelitz D. Activation of human gamma delta T cells by Mycobacterium tuberculosis and Daudi lymphoma cells: differential regulatory effect of IL-10 and IL-12. J Immunol. 1997;158:2842-2848.
-
(1997)
J Immunol
, vol.158
, pp. 2842-2848
-
-
Marx, S.1
Wesch, D.2
Kabelitz, D.3
-
27
-
-
0026701132
-
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells
-
D'Andrea A, Rengaraju M, Valiante NM, et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med. 1992;176: 1387-1398.
-
(1992)
J Exp Med
, vol.176
, pp. 1387-1398
-
-
D'Andrea, A.1
Rengaraju, M.2
Valiante, N.M.3
-
28
-
-
0031419058
-
Patterns of phosphoantigen stimulation of human Vgamma9/Vdelta2 T cell clones include Th0 cytokines
-
Sireci G, Champagne E, Fournie JJ, et al. Patterns of phosphoantigen stimulation of human Vgamma9/Vdelta2 T cell clones include Th0 cytokines. Hum Immunol. 1997;58: 70-82.
-
(1997)
Hum Immunol
, vol.58
, pp. 70-82
-
-
Sireci, G.1
Champagne, E.2
Fournie, J.J.3
-
29
-
-
0029818954
-
Interleukin-12 activates human gamma delta T cells: Synergistic effect of tumor necrosis factor-alpha
-
Ueta C, Kawasumi H, Fujiwara H, et al. Interleukin-12 activates human gamma delta T cells: synergistic effect of tumor necrosis factor-alpha. Eur J Immunol. 1996;26:3066-3073.
-
(1996)
Eur J Immunol
, vol.26
, pp. 3066-3073
-
-
Ueta, C.1
Kawasumi, H.2
Fujiwara, H.3
-
30
-
-
0025814690
-
In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: Increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma
-
Harwood HJ Jr, Alvarez IM, Noyes WD, et al. In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma. J Lipid Res. 1991;32:1237-1252.
-
(1991)
J Lipid Res
, vol.32
, pp. 1237-1252
-
-
Harwood Jr, H.J.1
Alvarez, I.M.2
Noyes, W.D.3
-
31
-
-
0033613355
-
Activation of the cholesterol pathway and Ras maturation in response to stress
-
Shack S, Gorospe M, Fawcett TW, et al. Activation of the cholesterol pathway and Ras maturation in response to stress. Oncogene. 1999;18:6021-6028.
-
(1999)
Oncogene
, vol.18
, pp. 6021-6028
-
-
Shack, S.1
Gorospe, M.2
Fawcett, T.W.3
-
32
-
-
74349084623
-
CD40 ligation restores type 1 polarizing capacity in TLR4 activated dendritic cells that have ceased interleukin-12 expression
-
Nov. 8 [Epub ahead of print] (PMID: 19017356)
-
Dohnal AM, Luger R, Paul P, et al. CD40 ligation restores type 1 polarizing capacity in TLR4 activated dendritic cells that have ceased interleukin-12 expression. J Cell Mol Med. 2008. Nov. 8 [Epub ahead of print] (PMID: 19017356).
-
(2008)
J Cell Mol Med
-
-
Dohnal, A.M.1
Luger, R.2
Paul, P.3
-
33
-
-
18544364477
-
Potential regulatory function of human dendritic cells expressing indoleamine 2, 3-dioxygenase
-
Munn DH, Sharma MD, Lee JR, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2, 3-dioxygenase. Science. 2002;297:1867-1870.
-
(2002)
Science
, vol.297
, pp. 1867-1870
-
-
Munn, D.H.1
Sharma, M.D.2
Lee, J.R.3
-
34
-
-
0035885874
-
Differentiation of resting human peripheral blood gamma delta T cells toward Th1-or Th2-phenotype
-
Wesch D, Glatzel A, Kabelitz D. Differentiation of resting human peripheral blood gamma delta T cells toward Th1-or Th2-phenotype. Cell Immunol. 2001;212:110-117.
-
(2001)
Cell Immunol
, vol.212
, pp. 110-117
-
-
Wesch, D.1
Glatzel, A.2
Kabelitz, D.3
-
35
-
-
0037363585
-
Immunoregulation in the tissues by gammadelta T cells
-
Hayday A, Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol. 2003;3:233-242.
-
(2003)
Nat Rev Immunol
, vol.3
, pp. 233-242
-
-
Hayday, A.1
Tigelaar, R.2
-
36
-
-
0037386125
-
Adaptive immune response of Vgam-ma2Vdelta2 T cells: A new paradigm
-
Chen ZW, Letvin NL. Adaptive immune response of Vgam-ma2Vdelta2 T cells: a new paradigm. Trends Immunol. 2003;24: 213-219.
-
(2003)
Trends Immunol
, vol.24
, pp. 213-219
-
-
Chen, Z.W.1
Letvin, N.L.2
-
37
-
-
0030900339
-
Comparative analysis of alpha beta and gamma delta T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate
-
Wesch D, Marx S, Kabelitz D. Comparative analysis of alpha beta and gamma delta T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate. Eur J Immunol. 1997;27:952-956.
-
(1997)
Eur J Immunol
, vol.27
, pp. 952-956
-
-
Wesch, D.1
Marx, S.2
Kabelitz, D.3
-
40
-
-
33750934617
-
Dendritic cells: Translating innate to adaptive immunity
-
Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006;311:17-58.
-
(2006)
Curr Top Microbiol Immunol
, vol.311
, pp. 17-58
-
-
Steinman, R.M.1
Hemmi, H.2
-
41
-
-
3142724031
-
Toll-like receptor signalling
-
Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499-511.
-
(2004)
Nat Rev Immunol
, vol.4
, pp. 499-511
-
-
Akira, S.1
Takeda, K.2
-
43
-
-
0032482337
-
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
-
Ridge JP, Di-Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998;393:474-478.
-
(1998)
Nature
, vol.393
, pp. 474-478
-
-
Ridge, J.P.1
Di-Rosa, F.2
Matzinger, P.3
-
44
-
-
0032482474
-
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
-
Schoenberger SP, Toes RE, van-der-Voort EI, et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998;393:480-483.
-
(1998)
Nature
, vol.393
, pp. 480-483
-
-
Schoenberger, S.P.1
Toes, R.E.2
Van-Der-Voort, E.I.3
-
45
-
-
2642631750
-
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
-
Jonuleit H, Kuhn U, Muller G, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol. 1997;27:3135-3142.
-
(1997)
Eur J Immunol
, vol.27
, pp. 3135-3142
-
-
Jonuleit, H.1
Kuhn, U.2
Muller, G.3
-
46
-
-
0037066427
-
The danger model: A Renewed Sense of Self
-
Matzinger P. The danger model: a Renewed Sense of Self. Science. 2002;296:301-305.
-
(2002)
Science
, vol.296
, pp. 301-305
-
-
Matzinger, P.1
-
47
-
-
33748142396
-
Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells
-
Lin AM, Hershberg RM, Small EJ. Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells. Urol Oncol. 2006;24:434-441.
-
(2006)
Urol Oncol
, vol.24
, pp. 434-441
-
-
Lin, A.M.1
Hershberg, R.M.2
Small, E.J.3
-
48
-
-
33645325115
-
Dacarba-zine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: A randomized phase III trial of the DC study group of the DeCOG
-
Schadendorf D, Ugurel S, Schuler-Thurner B, et al. Dacarba-zine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol. 2006;17: 563-570.
-
(2006)
Ann Oncol
, vol.17
, pp. 563-570
-
-
Schadendorf, D.1
Ugurel, S.2
Schuler-Thurner, B.3
|